This protein is a core regulatory subunit of the mitochondrial calcium uniporter complex (MCU), which mediates calcium uptake into mitochondria to modulate cellular energy production, apoptosis, and signal transduction . Key roles include:
Calcium Homeostasis: Acts as an essential MCU regulator, enabling calcium-dependent activation of mitochondrial metabolism .
Structural Role: Integral single-pass membrane protein localized to the mitochondrial inner membrane, critical for maintaining uniplex complex stability .
The recombinant protein is widely used to investigate:
Recent studies in Xenopus laevis spinal cord injury models highlight mitochondrial adaptations during neural stem/progenitor cell (NSPC) proliferation. While not directly tested here, UPF0466 homologs are implicated in metabolic shifts (e.g., glycolysis) required for tissue regeneration .
Produced in E. coli expression systems, the protein undergoes stringent quality assessments:
KEGG: xla:495205
UniGene: Xl.86014
The UPF0466 protein C22orf32 homolog is a mitochondrial protein expressed in Xenopus laevis (African clawed frog). This protein belongs to the UPF (Uncharacterized Protein Family) classification, specifically UPF0466, indicating it has a recognized protein structure but its function remains incompletely characterized . The mitochondrial localization suggests potential roles in energy metabolism, mitochondrial maintenance, or signaling pathways between mitochondria and other cellular compartments. This recombinant protein provides researchers with a purified form for investigating its structure-function relationships and potential role in mitochondrial biology.
The amino acid sequence of the UPF0466 protein C22orf32 homolog from Xenopus laevis is:
VIASSAGAILPKPEKVSFGLLRVFTVVIPFLYIGTLISKNFAAVLEEHDIFVPEDDDDDD
The full-length protein has an expression region spanning amino acids 38-97, suggesting that the active or functional domain is contained within this segment . The sequence contains a mixture of hydrophobic and hydrophilic residues, with a notably acidic C-terminal region (multiple aspartic acid residues). This structural feature may be important for protein-protein interactions or ion binding. The protein's mitochondrial localization also suggests it likely contains sequences that facilitate import into the mitochondrial compartment.
The Xenopus laevis UPF0466 protein C22orf32 homolog is related to the human C22orf32 protein (indicated by "homolog" in its name). While the exact sequence homology is not specified in the provided information, the conservation of this protein across evolutionary distance (from amphibians to humans) suggests functional importance . Researchers should consider that functional domains are likely to be more conserved than non-functional regions. When designing experiments, it's important to recognize that findings in the Xenopus model may have translational relevance for understanding human mitochondrial biology, though species-specific differences in regulation and interaction partners may exist.
For optimal stability and activity preservation of the Recombinant Xenopus laevis UPF0466 protein C22orf32 homolog:
Store the protein at -20°C for standard storage
For extended preservation, store at -80°C
The protein is supplied in a Tris-based buffer with 50% glycerol, optimized specifically for this protein's stability
Avoid repeated freeze-thaw cycles as this can lead to protein denaturation and activity loss
Working aliquots can be maintained at 4°C for up to one week
When preparing experimental aliquots, use appropriate buffer conditions that maintain protein solubility and activity
These handling precautions are critical for maintaining the structural integrity and biological activity of the protein during experimental procedures.
For effective protein-protein interaction (PPI) studies with the UPF0466 protein:
Co-immunoprecipitation approaches: Leverage the recombinant protein with appropriate antibodies or use as a standard to validate pull-down experiments.
Proximity ligation assays: Utilize specific antibodies against UPF0466 and potential binding partners to visualize interactions within mitochondria.
Yeast two-hybrid screening: Consider using the UPF0466 coding sequence as bait to identify potential interaction partners from Xenopus or other relevant expression libraries.
Surface Plasmon Resonance (SPR): Immobilize the recombinant protein on sensor chips to determine binding kinetics with potential interacting proteins.
Cross-linking mass spectrometry: Employ chemical cross-linking followed by mass spectrometry analysis to identify proximal proteins in a mitochondrial environment.
When designing these experiments, consider that this protein is localized to mitochondria and may function within mitochondrial protein complexes . Experimental conditions should account for the protein's potential role in mitochondrial networks, and interaction studies should include appropriate controls to distinguish specific from non-specific interactions.
To investigate the UPF0466 protein's role in mitochondrial function:
Mitochondrial respiration assays: Measure oxygen consumption rates in cells where UPF0466 protein levels have been modulated (overexpression or knockdown) to assess impacts on respiratory capacity.
Mitochondrial membrane potential analysis: Use fluorescent dyes like TMRM or JC-1 to evaluate whether the protein affects mitochondrial membrane potential, a key indicator of mitochondrial health.
ROS production measurement: Determine if the protein influences ROS generation using probes such as MitoSOX to detect mitochondrial superoxide production.
Mitochondrial dynamics assessment: Analyze mitochondrial morphology and network characteristics using fluorescence microscopy after modulating protein expression.
mtDNA stability and replication studies: Examine whether UPF0466 affects mitochondrial DNA maintenance by quantifying mtDNA copy number and integrity.
When interpreting results, consider that mitochondrial dysfunction mechanisms are complex and often interrelated, with cascading effects on multiple pathways . The protein may influence one or more aspects of mitochondrial biology including bioenergetics, quality control, or signaling pathways like cGAS-STING that detect mtDNA release during mitochondrial stress .
The UPF0466 protein may play a role in mitochondrial stress response through several potential mechanisms:
Mitochondrial quality control: It could participate in pathways that detect damaged mitochondria and trigger mitophagy, similar to PINK1/Parkin mechanisms.
mtDNA stability regulation: The protein might protect mtDNA from damage during oxidative stress or assist in mtDNA repair mechanisms.
Mitochondrial unfolded protein response (UPRmt): UPF0466 may function in stress-activated pathways that upregulate mitochondrial chaperones and proteases.
Metabolic adaptation: During stress conditions, it could mediate shifts in metabolic pathways, potentially through interacting with key enzymes.
Mitochondrial dynamics regulation: The protein might influence fission/fusion processes that help segregate damaged mitochondrial components.
Recent research has demonstrated that mitochondrial stress can activate various signaling pathways, including those involving AMPK, mTOR, and cGAS-STING, which detect cytosolic mtDNA released during stress . Investigating whether UPF0466 interacts with or modulates any of these pathways could provide insights into its function during mitochondrial stress.
To investigate post-translational modifications (PTMs) of the UPF0466 protein:
Mass spectrometry analysis:
Perform high-resolution LC-MS/MS on purified protein to identify modification sites
Use targeted approaches like Multiple Reaction Monitoring (MRM) for specific PTMs
Compare PTM profiles under different cellular conditions (normal vs. stress)
Site-directed mutagenesis:
Generate mutants at potential modification sites to assess functional consequences
Create phosphomimetic mutations (S/T to D/E) or non-modifiable variants (S/T to A)
PTM-specific antibodies:
Use commercially available or custom-developed antibodies against common PTMs (phosphorylation, acetylation, etc.)
Perform western blotting under different cellular conditions
In vitro enzymatic assays:
Test whether the recombinant protein can serve as a substrate for specific modifying enzymes
Assess how modifications affect protein activity or interactions
When analyzing results, consider that PTMs often occur in response to specific stimuli or stress conditions . The mitochondrial localization of UPF0466 suggests that relevant modifications might be regulated by mitochondrial kinases, acetyltransferases, or other modifying enzymes that respond to mitochondrial metabolic state or stress.
To investigate evolutionary conservation of mitochondrial pathways using UPF0466:
Comparative sequence analysis:
Perform multiple sequence alignments of UPF0466 homologs across species
Identify conserved domains and residues as potential functional regions
Calculate evolutionary rates for different protein segments
Functional complementation studies:
Express Xenopus UPF0466 in other species with deficient homologs
Assess rescue of phenotypes to determine functional conservation
Protein structure prediction and comparison:
Use AlphaFold or similar tools to predict structures of UPF0466 from different species
Compare structural conservation despite sequence divergence
Interactome analysis:
Compare protein interaction networks across species
Identify conserved binding partners versus species-specific interactions
This evolutionary approach may reveal insights about fundamental mitochondrial processes that have been conserved from amphibians to mammals . Conserved features often indicate functional importance, while divergent regions may reflect species-specific adaptations in mitochondrial function.
When validating antibody specificity for UPF0466 protein:
Western blotting with recombinant protein:
Use the purified recombinant UPF0466 protein as a positive control
Include related proteins as specificity controls
Test against mitochondrial extracts from Xenopus tissues
Immunocytochemistry validation:
Overexpress tagged UPF0466 and confirm co-localization with antibody signal
Use siRNA/shRNA knockdown to demonstrate signal reduction
Co-stain with mitochondrial markers to confirm expected localization
Immunoprecipitation specificity:
Perform IP followed by mass spectrometry to confirm target protein recovery
Use recombinant protein for competitive blocking in IP experiments
Knockout/knockdown controls:
Generate CRISPR knockout or reliable knockdown models
Demonstrate absence of signal in these models
Each validation method has strengths and limitations, and combining multiple approaches provides the most reliable confirmation of antibody specificity . For mitochondrial proteins like UPF0466, subcellular fractionation quality is crucial to avoid false positive results from antibodies cross-reacting with cytosolic proteins.
When designing functional assays for UPF0466 protein:
Subcellular localization confirmation:
Verify mitochondrial localization using fractionation and microscopy
Determine the specific mitochondrial compartment (outer membrane, intermembrane space, inner membrane, or matrix)
Physiological conditions:
Conduct assays under conditions that mimic mitochondrial environment (pH, ion concentrations)
Consider normal vs. stressed mitochondrial states
Expression level control:
Ensure expression levels in recombinant systems are physiologically relevant
Use inducible systems to control expression timing and level
Functional readouts:
Select appropriate mitochondrial function parameters (membrane potential, ATP production, calcium handling, etc.)
Use multiple complementary assays to build a comprehensive functional profile
Temporal considerations:
Assess both acute and chronic effects of protein modulation
Design time-course experiments to distinguish primary from secondary effects
When interpreting results, consider that mitochondrial proteins often have context-dependent functions that may vary with cell type, metabolic state, or stress conditions . Control experiments should include appropriate positive controls that affect known mitochondrial pathways.
To effectively use UPF0466 recombinant protein as a standard:
Standard curve development:
Create serial dilutions of the recombinant protein ranging from 0.1-1000 ng/mL
Generate a standard curve for each experimental batch
Use statistical methods to determine limits of detection and quantification
Quality control measures:
Verify protein stability under assay conditions
Include internal reference standards across experiments
Monitor batch-to-batch variation of the recombinant protein
Assay optimization:
Determine the linear range for quantification
Optimize antibody concentrations and incubation conditions
Minimize matrix effects from complex biological samples
Data normalization approaches:
Consider total protein normalization or housekeeping protein references
For mitochondrial studies, normalize to mitochondrial markers like VDAC or citrate synthase
When using recombinant proteins as standards, ensure that post-translational modifications or structural features relevant to the assay are appropriately represented in the standard . For accurate quantification in complex samples, consider potential interfering substances and validate recovery rates by spike-in experiments.
The UPF0466 protein may enhance our understanding of mitochondrial diseases through:
Novel mitochondrial pathway identification:
Characterizing UPF0466's function could reveal previously unknown mitochondrial processes
Uncovering its interactome may highlight new disease-relevant protein networks
Stress response mechanisms:
Investigating how UPF0466 responds to mitochondrial stress could illuminate adaptive or pathological changes
Understanding its role in maintaining mitochondrial homeostasis may reveal disease-relevant vulnerable points
Therapeutic target assessment:
Determining whether modulation of UPF0466 affects disease-relevant phenotypes
Exploring whether it functions in known therapeutic pathways like mitophagy or mitochondrial biogenesis
Biomarker potential:
Evaluating whether UPF0466 levels or modifications correlate with mitochondrial dysfunction
Investigating its release during mitochondrial damage as a potential circulating biomarker
Recent research has shown that mitochondrial dysfunction contributes to numerous diseases, including neurodegeneration, cardiovascular disease, and metabolic disorders . Proteins like UPF0466 that are conserved across species may represent fundamental components of mitochondrial biology whose dysfunction could contribute to disease processes through mechanisms involving energy production, calcium handling, ROS generation, or mtDNA maintenance.
To investigate UPF0466's potential influence on mtDNA stability:
mtDNA damage and repair assays:
Measure mtDNA lesions using qPCR techniques after oxidative stress
Assess mtDNA repair kinetics in cells with modified UPF0466 expression
Use techniques like Long-range PCR to detect large-scale mtDNA damage
Nucleoid analysis:
Perform super-resolution microscopy to visualize mtDNA nucleoids
Assess nucleoid number, size, and distribution when UPF0466 is manipulated
Use proximity ligation assays to test UPF0466 interaction with nucleoid proteins
mtDNA replication studies:
Measure mtDNA synthesis rates using BrdU incorporation
Assess the impact on mtDNA copy number regulation
Examine potential interactions with mtDNA replication machinery components
mtDNA release monitoring:
Quantify cytosolic mtDNA using fractionation approaches
Assess activation of cGAS-STING pathway as a marker of mtDNA release
Measure inflammatory responses that may result from mtDNA escape
Recent studies have demonstrated that mitochondrial stress can lead to mtDNA release into the cytosol, activating inflammatory pathways like cGAS-STING . Proteins that maintain mtDNA integrity or regulate its compartmentalization play critical roles in preventing inappropriate immune activation. Determining whether UPF0466 functions in these pathways could reveal new insights into mitochondrial contribution to inflammatory processes.
Utilizing UPF0466 protein in mitochondrial transplantation research:
Mitochondrial tagging strategies:
Engineer UPF0466 with fluorescent tags to track transplanted mitochondria
Develop antibody-based methods to distinguish donor from recipient mitochondria
Quality assessment markers:
Investigate UPF0466 as a potential marker of mitochondrial health/functionality
Determine if UPF0466 levels or modifications predict transplantation success
Functional integration studies:
Monitor UPF0466-associated processes to assess functional integration of transplanted mitochondria
Develop assays based on UPF0466 interactions to measure mitochondrial networking post-transplantation
Immunological response investigations:
Determine whether UPF0466 contributes to immunogenicity of transplanted mitochondria
Assess its potential role in recognition of foreign mitochondria
Mitochondrial transplantation has emerged as a promising therapeutic strategy for treating mitochondrial dysfunction in various diseases . Using well-characterized mitochondrial proteins like UPF0466 as experimental tools can help advance this field by improving our ability to track and assess transplanted mitochondria. Understanding the protein's normal function could also help optimize mitochondrial preparation protocols to preserve key functional capabilities.